Design Therapeutics, Inc. (DSGN)
NASDAQ·Healthcare·Biotechnology
$12.90
+0.66%
Mkt Cap $772.75M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 9, 2026 | — | — | — | -$0.38 | -$0.27 | +28.95% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.34 | -$0.30 | +11.76% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.32 | -$0.34 | -6.25% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$0.28 | -$0.31 | -10.71% | — | — |
| Q1 2025 Mar 10, 2025 | — | — | — | -$0.28 | -$0.24 | +14.29% | — | — |
| Q4 2024 Nov 7, 2024 | — | — | — | -$0.26 | -$0.23 | +11.54% | — | — |
| Q3 2024 Aug 5, 2024 | — | — | — | -$0.25 | -$0.21 | +16.00% | — | — |
| Q2 2024 May 8, 2024 | — | — | — | -$0.28 | -$0.20 | +28.57% | — | — |
| Q1 2024 Mar 19, 2024 | — | $838.00K | — | -$0.32 | -$0.21 | +34.38% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.42 | -$0.28 | +33.33% | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | -$0.41 | -$0.36 | +12.20% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$0.37 | -$0.35 | +5.41% | — | — |
| Q1 2023 Mar 14, 2023 | — | — | — | -$0.34 | -$0.31 | +8.82% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.28 | -$0.32 | -14.29% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.25 | -$0.27 | -8.00% | — | — |
| Q2 2022 May 9, 2022 | — | — | — | -$0.22 | -$0.24 | -9.09% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | -$0.22 | -$0.20 | +9.09% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$0.14 | -$0.21 | -50.00% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.18 | -$0.14 | +22.22% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.07 | -$0.31 | -342.86% | — | — |